All In Biotech

Free tool

FAERS Monitor: Omeprazole

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022032 or its brand name (Omeprazole, Omeprazole). Reports on generic versions are filed under their own applications.

Reports

349,834

Serious

257,872

74% of reports

Hospitalization

127,821

Death reported

31,667

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue21,082
  • nausea21,010
  • diarrhoea20,814
  • dyspnoea17,287
  • drug ineffective16,664
  • headache15,621
  • pain14,599
  • chronic kidney disease14,129
  • vomiting14,011
  • dizziness13,944
  • off label use13,640
  • acute kidney injury12,307
  • malaise11,464
  • arthralgia11,309
  • fall11,179

Reports by year received

View as table
YearReports
20042,484
20053,085
20063,080
20073,247
20084,328
20095,458
20107,438
20119,825
201212,809
201312,142
201414,808
201521,189
201623,504
201722,186
201828,715
201932,212
202025,703
202122,376
202221,235
202320,124
202419,421
202519,837
202614,619

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,704,325 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chronic kidney diseaseSignal14,12913.513.3133,654
acute kidney injurySignal12,3075.25.138,344
fallSignal11,1792.12.05,943
diarrhoea20,8142.01.99,923
dyspnoea17,2871.91.86,876
vomiting14,0111.81.85,097
dizziness13,9441.71.74,005
arthralgia11,3091.71.62,895
fatigue21,0821.61.65,393
nausea21,0101.61.64,941
malaise11,4641.61.62,474
headache15,6211.51.52,710
pain14,5991.41.41,968
off label use13,6400.90.962
drug ineffective16,6640.80.71,367

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.